Spittel, Susanne http://orcid.org/0000-0001-9471-7798
Meyer, Thomas http://orcid.org/0000-0002-2736-7350
Weyen, Ute
Grehl, Torsten
Weydt, Patrick
Steinbach, Robert http://orcid.org/0000-0003-3936-6010
Petri, Susanne
Baum, Petra
Metelmann, Moritz
Sperfeld, Anne-Dorte
Kettemann, Dagmar
Norden, Jenny
Rödiger, Annekathrin
Ilse, Benjamin
Grosskreutz, Julian
Hildebrandt, Barbara
Walter, Bertram
Münch, Christoph
Maier, André http://orcid.org/0000-0003-2473-4116
Funding for this research was provided by:
Kinova Europe GmbH
Charité - Universitätsmedizin Berlin
Article History
Received: 14 April 2024
Accepted: 9 August 2024
First Online: 23 August 2024
Declarations
:
: The study protocol was approved by the Medical Ethics Committee of Charité – Universitätsmedizin Berlin, Germany under number EA1/219/15. A signed patient information and informed consent form was obtained from all the participating patients.
: Not applicable.
: TM has received consulting fees from Cytokinetics, GSK and Desitin Arzneimittel GmbH; and has served on scientific advisory boards for Cytokinetics, GSK and TEVA. TM and CM are founders of the internet platform Ambulanzpartner and hold shares in Ambulanzpartner Soziotechnologie APST GmbH. AM has received presentation and consulting fees from Merz Pharma GmbH & Co., KGaA, and ITF Pharma GmbH. RS has received presentation fees from ITF Pharma outside of the submitted work. SP has participated on advisory boards of Biogen and has received consulting fees from Biogen. AR received speaker fees from Amylyx Pharmaceuticals and served on advisory boards for Biogen and Argenx outside of the submitted work. All other authors declare that they have no conflicts of interest.